Balancing ADT efficacy with cardiovascular safety

[madman]

Sanoj Punnen, MD, highlights the importance of assessing and managing cardiovascular risk when initiating androgen deprivation therapy for patients with prostate cancer.

 

[madman]

Thread 'Persistent Testosterone Suppression After Cessation of ADT for Prostate Cancer'

Jan 28, 2023

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer (2022)
Jessica Delgado, Jesse Ory, Justin Loloi, Nicholas A. Deebel, Ari Bernstein, Sirpi Nackeeran, Isaac Zucker, Ranjith Ramasamy


Abstract

Introduction

Many men receiving temporary androgen deprivation therapy (ADT) for localized prostate cancer fail to achieve baseline testosterone levels after cessation. Testosterone recovery in men with localized prostate cancer receiving temporary ADT was assessed.

Methods

A global federated health research network...

• madman
• prostate cancer; adt; hypogonadism; trt
• Replies: 9
• Forum: Prostate Related Issues